Skip to main content

Musculoskeletal Tissue Engineering

15
Publications
33.33
%Q1
34
Number of citations
70.00
% Open Access Publications
6
Ongoing Projects
2
Number of Presented Theses
0
Number of Active Clinical Trials
The mission of this group is to develop cell and tissue-based therapies in the field of regenerative medicine. They are focused in design, conduct and transform preclinical efforts into clinical trials mainly in bone regeneration that could be used in different indications. The team holds a high degree of knowledge and translational experience thanks to several years working in the field and have also established successful collaboration with partners from different fields. In 2024, our research group continued its work with the FIS research grant focusing on a tissue engineering allograft cell product for focal cartilage lesions.

eCORE

  • Advanced Therapies and Advanced Interventions, Nanomedicine, Transplant & Donation

Team

Group Leader
Roberto Vélez Villa

Principal Investigator (PI)
Joaquim Vives Nayana, Joshi Daniel Pacha

Researchers
Raquel Cabrera, Anna Server

Selected Publications

Casanova-Salas I, Aguilar D, Cordoba-Terreros S, Agundez L, Brandariz J, Herranz N, Mas A, Gonzalez M, Morales-Barrera R, Sierra A, Soriano-Navarro M, Cresta P, Mir G, Simonetti S, Rodrigues G, Arce-Gallego S, Delgado-Serrano L, Agustí I, Castellano-Sanz E, Mast R, de Albert M, Celma A, Santamaria A, Gonzalez L, Castro N, Suanes MDM, Hernández-Losa J, Nonell L, Peinado H, Carles J, Mateo J.
Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution
Cancer Cell. 2024 Jul 8;42(7):1301-1312.e7.
DOI: 10.1016/j.ccell.2024.06.003
IF: 48.8

Garcia-Ruiz A, Macarro C, Zacchi F, Morales-Barrera R, Grussu F, Casanova-Salas I, Sanguedolce F, Gonzalez M, Cresta-Morgado P, de Albert M, Garcia-Bennett J, Marmolejo D, Planas J, Roche S, Mast R, Zatse C, Piulats JM, Herrera-Imbroda B, Regis L, Agundez L, Olmos D, Calvo N, Escobar M, Carles J, Mateo J, Perez-Lopez R
Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial.
Eur Urol. 2024 Sep;86(3):272-274
DOI: 10.1016/j.eururo.2024.02.016
IF: 25.3

Bayes-Genis A, Gastelurrutia P, Monguió-Tortajada M, Cámara ML, Prat-Vidal C, Cediel G, Rodríguez-Gómez L, Teis A, Revuelta-López E, Ferrer-Curriu G, Roura S, Gálvez-Montón C, Bisbal F, Vives J, Vilarrodona A, Muñoz-Guijosa C, Querol S
Implantation of a double allogeneic human engineered tissue graft on damaged heart: insights from the PERISCOPE phase I clinical trial.
EBioMedicine. 2024 Apr;102:105060
DOI: 10.1016/j.ebiom.2024.105060
IF: 9.7

Server A, Boezaart AP, Perez-Carrasco M, Esteves-Coelho M, Laredo F, Reina MA
Identification of spread after deliberated intraneural injection in five mammalian species: not all animal models and needle types are valid for studying the effect of intraneural injections in humans
Reg Anesth Pain Med. 2024 Sep 2;49(9):677-687
DOI: 10.1136/rapm-2023-104820
IF: 5.1

Boezaart A, Reina MA, McLeod GA, van Niekerk D, Server A, Sala-Blanch X.
Revisiting human nerve fascicle penetrability: a further response to Orebaugh and Ligocki
Reg Anesth Pain Med. 2024 Dec 31:rapm-2024-106286.
DOI: 10.1136/rapm-2024-106286
IF: 5.1

Selected Projects

Traslación de un producto alogénico de ingeniería tisular para el tratamiento de lesiones focales del cartílago articular.
Principal Investigator: Joaquim Vives
Agency: ISCIII
Funding: 132,000 €
Period: 2022-2025

Pot un tercer clau intramedul·lar flexible ser una opció de tractament en fractures diafisàries de fèmur inestables? Anàlisi biomecànica
Principal Investigator: Daniel Alejandro Pacha Vicente
Agency: Acadèmia Ciències Mèdiques Catalunya i Balears
Funding: 8,000 €
Period: 2023-2025

SHARESPACE: Embodied Social Experiences in Hybrid Shared Spaces
Principal Investigator: Anna Server Salvà
Agency: EUROPEAN COMMISSION
Funding: 144,620 €
Period: 2023-2025

VHIR Annual Report 2024